On March 10, the Department of Justice (DOJ) moved to drop a lawsuit filed on behalf of the Federal Trade Commission (FTC) against Xlear, ...

Xlear says the move calls FTC’s authority to require clinical studies for non-pharmaceutical health products into question.

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Emergent BioSolutions (EBS) and Rocketvax announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets, ...